SCHEMBL31728395

SCHEMBL31728395

Cc1c(Cl)cccc1-c1cnc(OCc2ccn(C)n2)c2c(N)ncnc12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34
▸ CSF1R P07333 2/20 0.33
▸ ALOX5AP P20292 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ GRM2 Q14416 1/20 0.32
▸ PIK3CD O00329 2/20 0.31
▸ MPO P05164 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ KRAS P01116 1/20 0.31
▸ PIK3CA P42336 1/20 0.30
▸ PIK3CB P42338 1/20 0.30
▸ PIK3CG P48736 1/20 0.30
▸ PRKDC P78527 1/20 0.30
▸ METTL3 Q86U44 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728860 0.83 ALOX5AP (0.37) PDCD1CD274HDAC1HDAC6HDAC5
SCHEMBL31727769 0.82 GRM2 (0.36) PDCD1CD274HDAC1HDAC6HDAC5
SCHEMBL31728359 0.79 EPHB4 (0.36) PDCD1CD274PIK3CDPIK3CAPIK3CB
SCHEMBL31728178 0.78 GRM2 (0.37) HDAC1HDAC6HDAC5ALOX5APFEN1
SCHEMBL31728766 0.74 PIK3CD (0.38) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL31728800 0.67 CRHR1 (0.39) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL31729240 0.67 PIK3CD (0.37) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL31727895 0.64 PIK3CD (0.38) CSF1RPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL31729194 0.64 EIF2AK3 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL27801547 0.63 TSHR (0.46) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback